SMC accepts fondaparinux (Arixtra) for treatment of unstable ...
The Scottish Medicines Consortium (SMC) has accepted fondaparinux (Arixtra®) for use within NHS Scotland for the treatment of unstable angina or non-ST segment elevation myocardial infarction (UA/NSTEMI) in patients for whom urgent ...